Hangzhou Muhua Bio-Tech

Hangzhou Muhua Bio-Tech is a biotechnology company based in Hangzhou, China, specializing in the development of mRNA-based therapeutics and vaccines. The company has built a proprietary technology platform that encompasses mRNA sequence optimization, chemical modification, and advanced lipid nanoparticle (LNP) delivery systems. Muhua Bio-Tech focuses on addressing significant unmet medical needs in the fields of infectious disease prevention and oncology immunotherapy. Their integrated approach allows for rapid development from initial drug design through to GMP-compliant manufacturing. The company is currently advancing a pipeline of mRNA candidates through pre-clinical studies, aiming to provide more effective and accessible genomic medicines.